A national database cohort study reveals infection risks associated with SGLT2 inhibitors in type 2 diabetes, suggesting careful monitoring is necessary.
We sincerely appreciate the insightful comments from the experts regarding our study on SGLT2 inhibitors and latent tuberculosis infection
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: